Specifically, it should be noted that ABCG1, ABCA1 and ACSL3 were negatively, while KAT2B positively, associated with all signatures of statin use, CpG methylation and diabetes risk/status (Supplementary Tables S3, S4). This evidence concerns the gene KAT2B and diabetes mellitus.